$2.79
0.051.82%
Pre-Market: 8:57 AM EDT
Comments
Loading...
ImmunityBio Earnings Estimates, EPS & Revenue | NASDAQ:IBRX | Benzinga
ImmunityBio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.160
Quarterly Revenue Estimate
$20.03M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$14.74M
Analyze the earnings history of ImmunityBio using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IBRX | ImmunityBio | -$0.20 | -$0.16 | — | — | $40.00K | $20.03M | — | — | 05/08/2025 | Get Alert |
| IBRX | ImmunityBio | -$0.38 | -$0.26 | -$0.09 | 65.38% | $139.00K | $8.74M | $7.55M | -13.59% | 03/03/2025 | Get Alert |
| IBRX | ImmunityBio | -$0.19 | -$0.17 | -$0.14 | 17.65% | $82.00K | $4.36M | $6.11M | 40.05% | 11/12/2024 | Get Alert |
| IBRX | ImmunityBio | -$0.32 | -$0.17 | -$0.20 | -17.65% | $41.00K | $2.52M | $1.05M | -58.45% | 08/12/2024 | Get Alert |
| IBRX | ImmunityBio | -$0.27 | -$0.16 | -$0.20 | -25.00% | $360.00K | $20.00K | $40.00K | 100.00% | 05/09/2024 | Get Alert |
| IBRX | ImmunityBio | -$0.27 | -$0.18 | -$0.38 | -111.11% | $73.00K | $20.00K | $139.00K | 595.00% | 03/19/2024 | Get Alert |
| IBRX | ImmunityBio | -$0.28 | -$0.27 | -$0.19 | 29.63% | $118.00K | $30.00K | $82.00K | 173.33% | 11/09/2023 | Get Alert |
| IBRX | ImmunityBio | -$0.24 | -$0.23 | -$0.32 | -39.13% | $35.00K | — | $41.00K | — | 08/08/2023 | Get Alert |
| IBRX | ImmunityBio | -$0.26 | $0.00 | -$0.27 | -100.00% | $14.00K | $360.00K | $360.00K | 0.00% | 05/11/2023 | Get Alert |
| IBRX | ImmunityBio | -$0.23 | -$0.22 | -$0.27 | -22.73% | $390.00K | $30.00K | $73.00K | 143.33% | 03/01/2023 | Get Alert |
| IBRX | ImmunityBio | -$0.22 | — | -$0.22 | — | $66.00K | — | $118.00K | — | 11/09/2022 | Get Alert |
| IBRX | ImmunityBio | -$0.23 | — | -$0.24 | — | $339.00K | — | $35.00K | — | 08/08/2022 | Get Alert |
| IBRX | ImmunityBio | -$0.21 | — | -$0.26 | — | $139.00K | — | $14.00K | — | 05/10/2022 | Get Alert |
| IBRX | ImmunityBio | -$0.18 | — | -$0.23 | — | -$147.00K | — | $390.00K | — | 03/02/2022 | Get Alert |
| IBRX | ImmunityBio | -$0.17 | — | -$0.22 | — | $151.00K | — | $66.00K | — | 11/12/2021 | Get Alert |
| IBRX | ImmunityBio | — | — | -$0.23 | — | — | — | $339.00K | — | 08/12/2021 | Get Alert |
| IBRX | ImmunityBio | — | — | -$0.21 | — | — | — | $139.00K | — | 05/14/2021 | Get Alert |
| IBRX | ImmunityBio | — | — | -$0.89 | — | — | — | $111.00K | — | 03/04/2021 | Get Alert |
ImmunityBio (IBRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $-0.09 | $-0.26 | 65.4 % |
| Q3 | 2024-11-12 | $-0.14 | $-0.17 | 17.6 % |
| Q2 | 2024-08-12 | $-0.20 | $-0.17 | -17.6 % |
| Q1 | 2024-05-09 | $-0.20 | $-0.16 | -25.0 % |
ImmunityBio (IBRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $7.55M | $8.74M | -13.6 % |
| Q3 | 2024-11-12 | $6.11M | $4.36M | 40.1 % |
| Q2 | 2024-08-12 | $1.05M | $2.52M | -58.5 % |
| Q1 | 2024-05-09 | $40.00K | $20.00K | 100.0 % |
FAQ
When is ImmunityBio (NASDAQ:IBRX) reporting earnings?
ImmunityBio (IBRX) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on March 3, 2025 for Q4.
What were the latest earnings per share (EPS) for ImmunityBio (NASDAQ:IBRX)?
The Actual EPS was $-0.09, which beat the estimate of $-0.26.
What were ImmunityBio’s (NASDAQ:IBRX) revenues?
The Actual Revenue was $7.6M, which missed the estimate of $8.7M.
Browse earnings estimates, EPS, and revenue on all stocks.